Future studies that involve assessing the T cell phenotypes in these DPEP1-KO mice as well as tumor responsiveness to ICI could lead to the development of combination treatments for reversing an immune exclusion phenotype, as we found an upregulation of PD-L1 in the KO setting (24, 73, 74). This evidence concerns the gene DPEP1 and neoplasm.